IKENA ONCOLOGY INC's ticker is IKNA and the CUSIP is 45175G108. A total of 40 filers reported holding IKENA ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,796,099 | -34.0% | 3,186,166 | 0.0% | 0.29% | -22.7% |
| Q2 2023 | $20,901,249 | +90.1% | 3,186,166 | 0.0% | 0.38% | +75.5% |
| Q1 2023 | $10,992,273 | +40.8% | 3,186,166 | +8.6% | 0.22% | +45.0% |
| Q4 2022 | $7,804,283 | -25.1% | 2,933,941 | 0.0% | 0.15% | -22.8% |
| Q3 2022 | $10,415,000 | -19.9% | 2,933,941 | 0.0% | 0.19% | -18.2% |
| Q2 2022 | $12,997,000 | -27.4% | 2,933,941 | 0.0% | 0.24% | -18.6% |
| Q1 2022 | $17,897,000 | -51.4% | 2,933,941 | 0.0% | 0.29% | -38.7% |
| Q4 2021 | $36,792,000 | -0.6% | 2,933,941 | 0.0% | 0.47% | +16.2% |
| Q3 2021 | $37,026,000 | -10.1% | 2,933,941 | 0.0% | 0.41% | -2.4% |
| Q2 2021 | $41,193,000 | -50.3% | 2,933,941 | 0.0% | 0.42% | -46.2% |
| Q1 2021 | $82,884,000 | – | 2,933,941 | – | 0.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $30,611,000 | 3.87% |
| Omega Fund Management, LLC | 2,249,123 | $13,720,000 | 2.81% |
| CHI Advisors LLC | 814,755 | $4,970,000 | 2.11% |
| BVF INC/IL | 2,501,571 | $15,260,000 | 0.61% |
| Artal Group S.A. | 1,549,513 | $9,452,000 | 0.40% |
| Orbimed Advisors | 2,933,941 | $17,897,000 | 0.29% |
| Logos Global Management LP | 178,281 | $1,088,000 | 0.14% |
| HealthCor Management, L.P. | 287,621 | $1,754,000 | 0.12% |
| FARALLON CAPITAL MANAGEMENT LLC | 792,077 | $4,832,000 | 0.02% |
| Point72 Asset Management, L.P. | 348,696 | $2,127,000 | 0.01% |